Class IV Angina
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up Study (NCT02694861) | CryoLife, Inc. | 2016-03-01 |
| The PEARL 8.0 Post-Approval Study (NCT01845103) | Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. | 2013-09-01 |
| Cardiogenesis Transmyocardial Revascularization Registry (NCT01827319) | Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. | 2013-05-01 |
Track Class IV Angina automatically
Every clearance here is in the API, with alerts when new ones post.